The vpr Regulatory Gene of HIV
10.1007/978-3-642-78929-8_11
Crossref book-chapter
Springer Berlin Heidelberg
Current Topics in Microbiology and Immunology (297)
Bibliography

Levy, D. N., Refaeli, Y., & Weiner, D. B. (1995). The vpr Regulatory Gene of HIV. Transacting Functions of Human Retroviruses, 209–236.

Authors 3
  1. D. N. Levy (first)
  2. Y. Refaeli (additional)
  3. D. B. Weiner (additional)
References 96 Referenced 7
  1. Aguanno S, Bouche M, Adamo S, Molinaro M (1990) 12-O-Tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell Line. Cancer Res 50: 3377–3382 / Cancer Res by S Aguanno (1990)
  2. Arrigo SJ, Chen ISY (1991) Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev 5: 808–819 (10.1101/gad.5.5.808) / Genes Dev by SJ Arrigo (1991)
  3. Balliet JW, Kolson DL, Eiger G, Kim FM, McGann KA, Srinivasan A, Collman R (1994) Distinct effect in primary macrophages and lymphocytes of the human immunodeficiency virus typw 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary isolate. Virology 200: 623–631 (10.1006/viro.1994.1225) / Virology by JW Balliet (1994)
  4. Balotta C, Lusso P, Crowley R, Gallo RC, Franchini G (1993) Antisense phosphorothioate oligodeoxy-nucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 67: 4409–4414 (10.1128/JVI.67.7.4409-4414.1993) / J Virol by C Balotta (1993)
  5. Barre-Sinoussi F, Cherman JC, Rey F, Nugeyre MT, Chameret S, Gruest J, Dauguet C, Axlerblin C, Brun-Ve’zinet F, Rauzioux C, Rozenbaum W and Montagnier L (1984) Isolation of a T-lymphotropic retro-virus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868–871 (10.1126/science.6189183) / Science by F Barre-Sinoussi (1984)
  6. Bednarik DP, Folks TM (1992) Mechanisms of HIV-1 latency. AIDS 6: 3–16 (10.1097/00002030-199201000-00001) / AIDS by DP Bednarik (1992)
  7. Bednarik DRP, Mosca JD, Raj NBK (1987) Methylation as a modulator of expression of human immunodeficiency virus. J Virol 61: 1253–1257 (10.1128/JVI.61.4.1253-1257.1987) / J Virol by DRP Bednarik (1987)
  8. Bukrinsky Ml, Stanwick TL, Dempsey MP, Stevenson M (1991) Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254: 423–427 (10.1126/science.1925601) / Science by Ml Bukrinsky (1991)
  9. Butera ST, Perez VL, Wu B-Y, Nabel GJ, Folks TM (1991) Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J Virol 65: 4645–4653 (10.1128/JVI.65.9.4645-4653.1991) / J Virol by ST Butera (1991)
  10. Clapham PR (1991) Human immunodeficiency virus infectin of non-haematopoietic cells: the role of CD4 independent entry. Med Virol 1: 51–58 (10.1002/rmv.1980010110) / Med Virol by PR Clapham (1991)
  11. Clapham PR, Weber JN, Whitby D, Mclntosh K, Gagleish AG, Maddon PJ, Deen KC, Sweet RW, Weiss RA (1989) Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T-cells and monocytes but not for brain and muscle cells. Nature 337: 368–370 (10.1038/337368a0) / Nature by PR Clapham (1989)
  12. Clapham PR, Blanc D, Weiss RA (1991) Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181: 703–715 (10.1016/0042-6822(91)90904-P) / Virology by PR Clapham (1991)
  13. Cohen EA, Dehni G, Sodroski JG, Haseltine WH (1990a) Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 64: 3097–3099 (10.1128/JVI.64.6.3097-3099.1990) / J Virol by EA Cohen (1990)
  14. Cohen EA, Terwilliger EF, Jalinoos Y, Proulx J, Sodroski JG, Haseltine WH (1990b) Identification of HIV-1 vpr product and function. J AIDS 3: 11–18 / J AIDS by EA Cohen (1990)
  15. Cullen BR (1991) Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 65: 1053–1056 (10.1128/JVI.65.3.1053-1056.1991) / J Virol by BR Cullen (1991)
  16. Dahl KE, Burrage T, Jones F, Miller G (1990) Persistent nonproductive infection of Epstein-Barr virustransformed human B lymphocytes by human immunodeficiency virus type 1. J Virol 64: 1771–1783 (10.1128/JVI.64.4.1771-1783.1990) / J Virol by KE Dahl (1990)
  17. Daniel MD, Desrosiers RC (1989) Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies. AIDS 3: S131–S133 (10.1097/00002030-198901001-00019) / AIDS by MD Daniel (1989)
  18. Dedera D, Hu W, Vander Heyden N, Ratner L (1989) Viral protein R of human immunodeficiency virus types 1 and 2 is dispensible for replication and cytopathogenicity in lymphoid cells. J Virol 63: 3205–3208 (10.1128/JVI.63.7.3205-3208.1989) / J Virol by D Dedera (1989)
  19. Embretson J, Zupancic M, Beneke J, Till M, Wolinsky S, Ribas JL, Burke A, Haase AT (1993a) Analysis of human immunodeficiency virus-infected tissues by amplification of in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci USA 90: 357–361 (10.1073/pnas.90.1.357) / Proc Natl Acad Sci USA by J Embretson (1993)
  20. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner RK, Haase AT (1993b) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubatin period of AIDS. Nature (Lond) 362: 359–362 (10.1038/362359a0) / Nature: (Lond) by J Embretson (1993)
  21. Felber BK, Pavlakis GN (1993) Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression. AIDS 7: S51–S62 (10.1097/00002030-199301001-00007) / AIDS by BK Felber (1993)
  22. Felix CA, Chavez Kappel C, Mitsudomi T, Nau MM, Tsokos M, Crouch GD, Nisen PD, Winick NJ, Helman LJ (1992) Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res 52: 2243–2247 / Cancer Res by CA Felix (1992)
  23. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS (1987) Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800–802 (10.1126/science.3313729) / Science by TM Folks (1987)
  24. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS (1989) Tumor necrosis factor α induces expresssion of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 86: 2365–2368 (10.1073/pnas.86.7.2365) / Proc Natl Acad Sci USA by TM Folks (1989)
  25. Francini G, Rusche JR, O’Keeffe TJ, Wong-Staal F (1988) The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virions. AIDS Res Hum Retroviruses 4: 243–249 (10.1089/aid.1988.4.243) / AIDS Res Hum Retroviruses by G Francini (1988)
  26. Fukasawa M, Miura T, Hasegawa A, Morikawa S, Tsujimoto H, Miki K, Kitamura T, Hayami M (1988) Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature 333: 457–461 (10.1038/333457a0) / Nature by M Fukasawa (1988)
  27. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PA (1984) Human T-lymphotropic retrovirus, HTLV-III, isolated from AIDS patients and donors at risk for AIDS. Science 224: 500–503 (10.1126/science.6200936) / Science by RC Gallo (1984)
  28. Garrett ED, Tiley LS, Cullen BR (1991) Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J Virol 65: 1653–1657 (10.1128/JVI.65.3.1653-1657.1991) / J Virol by ED Garrett (1991)
  29. Gazzolo L, Macé K (1990) Regulation of HIV-1 replication in promonocytic U937 cells. Res Virol 141: 259–265 (10.1016/0923-2516(90)90030-M) / Res Virol by L Gazzolo (1990)
  30. Gendelman HE, Phelps W, Feigenbaum L, Ostrove JM, Adachi A, Howley PM, Khoury G, Ginsberg HS, Martin MA (1986) Transactivation of the human immunodeficiency virus long terminal repeat sequences by DNA viruses. Proc Natl Acad Sci USA 83: 9759–9763. (10.1073/pnas.83.24.9759) / Proc Natl Acad Sci USA by HE Gendelman (1986)
  31. Gras-Masse H, Ameisen JC, Boutillon C, Gesquiere JC, Vian S, Neyrinck JL, Drobecq H, Capron A, Tartar A (1990) A synthetic protein corresponding to the entire vpr gene product from the human immunodeficiency virus HIV-1 is recognized by antibodies from HIV-infected patients. Int J Pept Protein Res 36: 219–26 (10.1111/j.1399-3011.1990.tb00970.x) / Int J Pept Protein Res by H Gras-Masse (1990)
  32. Haggerty S, Dempsey MP, Bukrinsky MI, Guo L, Stevenson M (1991) Posttranslational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection. AIDS Res Hum Retroviruses 7: 501–510 (10.1089/aid.1991.7.501) / AIDS Res Hum Retroviruses by S Haggerty (1991)
  33. Hattori N, Michaels F, Fargnoli K, Marcon L, Gallo RC, Franchini G (1990) The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc Natl Acad Sci USA 87: 8080–8084 (10.1073/pnas.87.20.8080) / Proc Natl Acad Sci USA by N Hattori (1990)
  34. Heinzinger HE, Bukrinsky Ml, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nodividing cells. Proc Natl Acad USA 91: 7311–7315 (10.1073/pnas.91.15.7311) / Proc Natl Acad USA by HE Heinzinger (1994)
  35. Hiti AL, Bogenmann E, Gonzales F, Jones PA (1989) Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol Cell Biol 9: 4722–4730 (10.1128/MCB.9.11.4722) / Mol Cell Biol by AL Hiti (1989)
  36. Kappes JC, Morrow CD, Lee SW, Jameson BA, Kent SB, Hood LE, Shaw GM, Hahn BH (1988) Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. J Virol 62: 3501–3505 (10.1128/JVI.62.9.3501-3505.1988) / J Virol by JC Kappes (1988)
  37. Kestler HW III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651–662 (10.1016/0092-8674(91)90097-I) / Cell by HW Kestler III (1991)
  38. Kitano K, Baldwin GC, Raines MA, Golde DW (1990) Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood 76: 1980–1988 (10.1182/blood.V76.10.1980.1980) / Blood by K Kitano (1990)
  39. Lang SM, Weeger M, Stahl-Henning C, Coulibaly C, Hunsmann G, Müller J, Müller-Hermelink H, Fuchs D, Wachter H, Daniel MM, Desrosiers RC, Fleckenstein B (1993) Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol 67: 902–912 (10.1128/JVI.67.2.902-912.1993) / J Virol by SM Lang (1993)
  40. Lavallee C, Yao XJ, Ladha A, Gottlinger H, Haseltine WA, Cohen EA (1994) Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 particles. J Virol 68: 1926–1934 (10.1128/JVI.68.3.1926-1934.1994) / J Virol by C Lavallee (1994)
  41. Levy DN (1994) Studies of HIV-1 Vpr PhD thesis, University of Pennsylvania, Philadelphia, PA / Studies of HIV-1 Vpr PhD thesis by DN Levy (1994)
  42. Levy DN, Weiner DB (1993) HIV regulatory gene function analysis in a rhabdomyosarcoma cell line. In: Ginsberb HS, Brown F, Chanock RM, Lerner RA Vaccines93: modern approaches to new vaccines including the prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY / Vaccines93: modern approaches to new vaccines including the prevention of AIDS by DN Levy (1993)
  43. Levy DN, Fernandes LS, Williams WV, Weiner DB (1993) Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72: 541–550 (10.1016/0092-8674(93)90073-Y) / Cell by DN Levy (1993)
  44. Levy DN, Refaeli Y, MacGreggor RR, Weiner DB (1994) Serum vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 91: 10873–10877 (10.1073/pnas.91.23.10873) / Proc Natl Acad Sci USA by DN Levy (1994)
  45. Levy DN, Refaeli Y, Weiner DB (1995a) Extracellular vpr protein increases cellular permissiveness to HIV replication and reactivates virus from latency. J Virol (in press) (10.1128/JVI.69.2.1243-1252.1995)
  46. Levy DN, Refaeli Y, Weiner DB (1995b) (submitted for publication)
  47. Levy JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57: 183–289 (10.1128/MMBR.57.1.183-289.1993) / Microbiol Rev by JA Levy (1993)
  48. Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS (1984) Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225: 840–842 (10.1126/science.6206563) / Science by JA Levy (1984)
  49. Lu Y-L, Spearman P, Ratner L (1993) Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol 67: 6542–6550 (10.1128/JVI.67.11.6542-6550.1993) / J Virol by Y-L Lu (1993)
  50. Marck C (1988) “DNA Strider”: a “C” program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. Nucleic Acids Res 16: 1829–1836 (10.1093/nar/16.5.1829) / Nucleic Acids Res by C Marck (1988)
  51. McCune JM (1991) HIV-1 the infectivity process in vivo. Cell 64: 351–363 (10.1016/0092-8674(91)90644-E) / Cell by JM McCune (1991)
  52. Meylan PRA, Spina CA, Richman DD, Kombluth RS (1993) In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model for studying the cellular basis of HIV differential tropism. Virology 193: 256–267 (10.1006/viro.1993.1121) / Virology by PRA Meylan (1993)
  53. Mikovits JA, Raziuddin Gonda M, Ruta M, Lohrey NC, Kung H-F, Ruscetti FW (1990) Negative regulation of human immunodeficiency virus replication in monocytes. J Exp Med 171: 1705–1720 (10.1084/jem.171.5.1705) / J Exp Med by JA Mikovits (1990)
  54. Mikovits JA, Lohrey NC, Schulof R, Courtlëss J, Ruscetti FW (1992) Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J Clin Invest 90: 1486–1491 (10.1172/JCI116016) / J Clin Invest by JA Mikovits (1992)
  55. Mosca JD, Bednarik DP, Raj NB, Rosen CA, Sodroski JG, Haseltine WA, Pitha PM (1987) herpes simplex virus type 1 can reactivate transcription of latent human immunodeficiency virus. Nature (Lond): 325: 67–70 (10.1038/325067a0) / Nature: (Lond): by JD Mosca (1987)
  56. Myers G, Korber B, Berzofsky JA, Smith RF, Pavlakis GN (1991) Hum Retroviruses AIDS III: 6–22 / AIDS by G Myers (1991)
  57. Ogawa K, Shibata R, Kiyomasu T, Higuchi I, Kishida Y, Ishimoto A, Adachi A (1989) Mutational analysis of the human immunodeficiency virus vpr open reading frame. J Virol 63: 4110–4114 (10.1128/JVI.63.9.4110-4114.1989) / J Virol by K Ogawa (1989)
  58. Oldstone MBA (1991) Molecular anatomy of viral persistence. J Virol 65: 6381–6386 (10.1128/JVI.65.12.6381-6386.1991) / J Virol by MBA Oldstone (1991)
  59. Pantaleo G, Graziosi C, Butini L, Pizzo PA, Schnittman SM, Kotler DP, Fauci AS (1991) Lymphoid organs function as major reserviors for human immunodeficiency virus. Proc Natl Acad Sci USA 88: 9838–9842 (10.1073/pnas.88.21.9838) / Proc Natl Acad Sci USA by G Pantaleo (1991)
  60. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (Lond) 362: 355–358 (10.1038/362355a0) / Nature: (Lond) by G Pantaleo (1993)
  61. Pautrat G, Suzan M, Salaun D, Corbreau P, Allasia C, Morel G, Filippi P (1990) Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. Virology 179: 749–758 (10.1016/0042-6822(90)90142-E) / Virology by G Pautrat (1990)
  62. Pavlakis GN, Schwartz S, D’Agostino DM, Felber BK (1992) Structure, splicing, and regulation of expression of HIV-1, a model for the general organization of lentiviruses and other complex retroviruses. In: AIDS Research Reviews, Vol. 2. Eds.: W.C. Koff, F. Wong-Staal, R.C. Kennedy, Marcel Dekker, Inc. N.Y., N.Y. / AIDS Research Reviews, Vol. 2 by GN Pavlakis (1992)
  63. Paxton W, Connor Rl, Landau NR (1993) Incorporation of vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol 67: 7229–7237 (10.1128/JVI.67.12.7229-7237.1993) / J Virol by W Paxton (1993)
  64. Perez VL, Rowe T, Justement JS, Butera ST, June CH, Folks TM (1991) An HIV-1 infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation. J Immunol 147: 3145–3148 (10.4049/jimmunol.147.9.3145) / J Immunol by VL Perez (1991)
  65. Perno C-F, Yarchoan R, Cooney DA, Hartman NR, Webb DSA, Hao Z, Mitsuya H, Johns DG, Broder S (1989) Replication of human immunodificiency virus in monocytes. J Exp Med 169: 933–951 (10.1084/jem.169.3.933) / J Exp Med by C-F Perno (1989)
  66. Pomerantz RJ, Trono D, Feinberg MB, Baltimore D (1990) Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61: 1271–1276 (10.1016/0092-8674(90)90691-7) / Cell by RJ Pomerantz (1990)
  67. Refaeli Y, Levy DN, Weiner DB (1995) (submitted for publication)
  68. Reiss P, Lange JM, de RA, de WF, Dekker J, Danner SA, Debouck C, Goudsmit J (1990) Antibody response to viral proteins U (vpu) and R(vpr) in HIV-1-infected individuals. J Acquir Immun Defic Syndr 3: 115–22 / J Acquir Immun Defic Syndr by P Reiss (1990)
  69. Rich EA, Chen ISY, Zack JA, Leonard ML, O’Brien WA (1992) Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 89: 176–183 (10.1172/JCI115559) / J Clin Invest by EA Rich (1992)
  70. Roulston A, D’Addario M, Boulerice F, Caplan S, Wainberg MA, Hiscott J (1992) Induction of monocytic differentiation and NF-KB-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J Exp Med 175: 751–763 (10.1084/jem.175.3.751) / J Exp Med by A Roulston (1992)
  71. Sato A, Igarashi H, Adachi A, Hayami M (1990) Identification and localization of vpr gene product of Human Immunodeficiency Virus Type 1. Virus Genes 4: 303–312 (10.1007/BF00570025) / Virus Genes by A Sato (1990)
  72. Schnittman SM, Psallidopoulos MC, Clifford Lane H, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS (1989) The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245: 305–308 (10.1126/science.2665081) / Science by SM Schnittman (1989)
  73. Schuitemaker H, Kootstra NA, Koppelman MHGM, Bruisten SM, Huisman HG, Tersmette M, Miedema F (1992) Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 89: 1154–1160 (10.1172/JCI115697) / J Clin Invest by H Schuitemaker (1992)
  74. Schüpbach J (1989) Human retrovirology. Facts and concepts. Springer, Berlin Heidelberg New York (Current Topics in Microbiology and immunology, vol 142) / Human retrovirology. Facts and concepts by J Schüpbach (1989)
  75. Shibata R, Miura T Hayami M, Ogawa K, Sakai H, Kiyomasu T, Ishimoto A, Adachi A (1990) Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIVAGM. J Virol 64: 742–747 (10.1128/JVI.64.2.742-747.1990) / J Virol by R Shibata (1990)
  76. Siegel HN, Lukas RJ (1988) Morphological and Biochemical Differentiation of the Human Medulloblastoma Cell Line TE671. Dev Brain Res 44: 269–280 (10.1016/0165-3806(88)90225-8) / Dev Brain Res by HN Siegel (1988)
  77. Silvennolnen O, Hure M (1990) Growth inhibition caused by serum depletion induces differentiation, interleukin 1 receptor expression and interleukin 1 responsiveness in the HL-60 promyelocytic leukemia cell line. Biochem Biophys Res Commun 168: 959–965 (10.1016/0006-291X(90)91122-9) / Biochem Biophys Res Commun by O Silvennolnen (1990)
  78. Srinivasan A, Goldsmith CS, York D, Anand R, Luciw P, Schochetman G, Palmer E, Bohan C (1988) Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch Virol 99: 21–30 (10.1007/BF01311020) / Arch Virol by A Srinivasan (1988)
  79. Stratton MR, Darling J, Pilkington GJ, Lantos PL, Reeves BR, Cooper CS (1989) Characterization of the human cell line TE671. Carcinogenesis 10: 899–905 (10.1093/carcin/10.5.899) / Carcinogenesis by MR Stratton (1989)
  80. Tateno M, Gonzalez-Scarano F, Levy JA (1989) Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci USA, 86: 4287–4290 (10.1073/pnas.86.11.4287) / Proc Natl Acad Sci USA, by M Tateno (1989)
  81. Terwilliger EF (1992) The accessory gene functions of the primate immunity viruses. In: Koff WC, Wong-Staal F, Kennedy RC (eds) AIDS Research Reviews vol 2. Marcel Dekker, New York / AIDS Research Reviews vol 2 by EF Terwilliger (1992)
  82. Tristem M, Marshal C, Karpas A, Hill F (1992) Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J 11: 3405–3412 (10.1002/j.1460-2075.1992.tb05419.x) / EMBO J by M Tristem (1992)
  83. Tristem M, Marshal C, Karpas A, Petrik J, Hill F (1990) Origin of vpx in lentiviruses. [Letter]. Nature (Lond) 347: 341–342 (10.1038/347341b0) / [Letter]. Nature: (Lond) by M Tristem (1990)
  84. Turpin JA, Vargo M, Meltzer MS (1992) Enhanced HIV-1 replication in retinoid-treated monocytes: retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 148: 2539–2546 (10.4049/jimmunol.148.8.2539) / J Immunol by JA Turpin (1992)
  85. Valentin A, Von Gegerfelt A, Matsuda S, Nilsson K, Åsjö B (1991) In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J AIDS 4: 751–759 / J AIDS by A Valentin (1991)
  86. Weiss RA, Clapham PR, McClure MO, McKeating JA, McKnight A, Dalgleish AG, Sattentau QJ, Weber JN (1988) Human immunodeficiency viruses: Neutralization and receptors. J AIDS 1: 536–541 / J AIDS by RA Weiss (1988)
  87. Werner A, Winskowsky G, Cichutek K, Norley SG, Kurth R (1990) Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVAGM. AIDS 6: 537–544 (10.1097/00002030-199006000-00007) / AIDS by A Werner (1990)
  88. Westervelt P, Henkel T, Trowbridge DB, Orenstein J, Heuser J, Gendelman HE, Ratner L (1992) Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J Virol 66: 3925–3931 (10.1128/JVI.66.6.3925-3931.1992) / J Virol by P Westervelt (1992)
  89. Winslow BJ, Pomerantz RJ, Bagasra O, Trono D (1993) HIV-1 latency due to the site of proviral integration. Virology 196: 849–854 (10.1006/viro.1993.1545) / Virology by BJ Winslow (1993)
  90. Wong-Staal F, Chanda PK, Ghrayeb J (1987) Human immunodeficiency virus: the eighth gene. AIDS Res Hum Retroviruses 3: 33–39 (10.1089/aid.1987.3.33) / AIDS Res Hum Retroviruses by F Wong-Staal (1987)
  91. Yu XF, Ito S, Essex M, Lee TH (1988) A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature 335: 262–265 (10.1038/335262a0) / Nature by XF Yu (1988)
  92. Yu XF, Yu QC, Essex M, Lee TH (1991) The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage. J Virol 65: 5088–5091 (10.1128/JVI.65.9.5088-5091.1991) / J Virol by XF Yu (1991)
  93. Yuan X, Matsuda Z, Matsuda M, Esex M, Lee T-H (1990) Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res Hum Retroviruses 6: 1265–1271 (10.1089/aid.1990.6.1265) / AIDS Res Hum Retroviruses by X Yuan (1990)
  94. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS (1990) HIV-1 entry into quiescent primary lymphocytes: moleuclar analysis reveals a labile, latent viral structure. Cell 61: 213–222 (10.1016/0092-8674(90)90802-L) / Cell by JA Zack (1990)
  95. Zack JA, Haislip AM, Krogstad P, Chen ISY (1992) Incompletely reverse- transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retrovial life cycle. J Virol 66: 1717–1725 (10.1128/JVI.66.3.1717-1725.1992) / J Virol by JA Zack (1992)
  96. Zhao L-J, Mukherjee S, Narayan O (1994) Biochemical mechanism of HIV-1 vpr function. Specific interaction with a cellular protein. Chem 289: 18877–15832 / Chem by L-J Zhao (1994)
Dates
Type When
Created 13 years, 9 months ago (Nov. 24, 2011, 10:33 p.m.)
Deposited 2 years, 2 months ago (June 11, 2023, 5:01 a.m.)
Indexed 11 months, 4 weeks ago (Sept. 6, 2024, 11:44 a.m.)
Issued 30 years, 8 months ago (Jan. 1, 1995)
Published 30 years, 8 months ago (Jan. 1, 1995)
Published Print 30 years, 8 months ago (Jan. 1, 1995)
Funders 0

None

@inbook{Levy_1995, title={The vpr Regulatory Gene of HIV}, ISBN={9783642789298}, ISSN={0070-217X}, url={http://dx.doi.org/10.1007/978-3-642-78929-8_11}, DOI={10.1007/978-3-642-78929-8_11}, booktitle={Transacting Functions of Human Retroviruses}, publisher={Springer Berlin Heidelberg}, author={Levy, D. N. and Refaeli, Y. and Weiner, D. B.}, year={1995}, pages={209–236} }